This record was last updated January 10, 2025 (before its estimated June 24, 2026 completion). Its status may not reflect the trial's current state.
Summary
Multicentre, Randomized, Double-blinded, Phase I/II Clinical Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of SCTT11 in Healthy Participants and Participants with Thyroid Eye Disease